Neurochemical effects of oxytocin in people at clinical high risk for psychosis.
Davies C, Rutigliano G, De Micheli A, Stone JM, Ramella-Cravaro V, Provenzani U, Cappucciati M, Scutt E, Paloyelis Y, Oliver D, Murguia S, Zelaya F, Allen P, Shergill S, Morrison P, Williams S, Taylor D, Lythgoe DJ, McGuire P, Fusar-Poli P.
Davies C, et al. Among authors: shergill s.
Eur Neuropsychopharmacol. 2019 May;29(5):601-615. doi: 10.1016/j.euroneuro.2019.03.008. Epub 2019 Mar 28.
Eur Neuropsychopharmacol. 2019.
PMID: 30928180